|
Publications: |
Vaccine Policy
The Centers for Disease Control and Prevention periodically update their recommendations for child and adult immunization schedules. In addition, each state of the USA has its own immunization requirements for school-age children. get immunization charts>>
2005 - The Twelfth Annual Sabin Vaccine Colloquium at Cold Spring Harbor
2004 - The Eleventh Annual Sabin Vaccine Colloquium at Cold Spring Harbor
2003 - The Tenth Annual Sabin Vaccine Colloquium at Cold Spring Harbor
2002 - The Ninth Annual Sabin Vaccine Colloquium at Cold Spring Harbor
2001 - The Eighth Annual Sabin Vaccine Colloquium at Cold Spring Harbor
2000 - The Seventh Annual Sabin Vaccine Colloquium at Cold Spring Harbor
1999 - The Sixth Annual Sabin Vaccine Colloquium at Cold Spring Harbor
A Moral Outrage: The Lack of Immunization Coverage in America
1995 - The Second Annual Sabin Vaccine Colloquium at Cold Spring Harbor
The dramatic changes occurring in the health care industry and the increasing importance of private sector providers in vaccine delivery led to an examination of the policies of major providers of immunization services and purchasers of vaccines. Barriers to vaccination and disincentives encountered by health care providers in both public and private sector programs were the subject of lively debate. The importance of accurate information on vaccination status of beneficiaries and target populations was repeatedly stressed.
1994 - The First Annual Sabin Vaccine Colloquium at Cold Spring Harbor
As science provides an ever increasing number of possible technologies, we will be faced with the challenge of selecting potential vaccines, and combinations of them with already existing vaccines, from a very large menu. This formidable task will involve numerous, frequently disparate, sectors of society. Academic researchers, the health care industry, private foundations, large and small industrial concerns, several government agencies, and a variety of advisory bodies, will all be involved in the complex decisions that line the long road between the identification of a need and the ultimate delivery of a preventive drug.
The "Biblical Diseases" and U.S. Vaccine Diplomacy. By Peter J. Hotez In 2000, 147 heads of state met at the United Nations headquarters in New York City to adopt a landmark set of eight Millennium Development Goals (MDGs) to achieve sustainable development for the world’s poorest people. Together with a set of 18 targets, the MDGs established a framework for combating poverty, disease, and environmental pollution by creating global partnerships between wealthy nations (especially the G8) and impoverished ones. read full text>>
Vaccine Diplomacy: The multinational effort to eliminate disease might not only save lives but prevent conflict. By Peter J. Hotez Vaccines are arguably one of humankind's greatest creations. Because of vaccines' remarkable ability to halt great plagues and eliminate disease, few others peacetime inventions have had as much influence on human history. Within the last 20 years alone, vaccines have eradicated smallpox, with polio soon to follow. But inoculations that eliminate disease could have an impact well beyond improving global health. Throughout the developing world, vaccines could also be transformed into powerful agents of conflict resolution. read full text>>
If you would like to receive a hardcopy of any of our publications, please fill out our feedback
form with your mailing information, and kindly specify in the comments
section the name of the publication you're requesting. You may also contact us for more information. Last updated: 11/1907 |
 | “A
scientist who is also a human being cannot rest | |
|---|
2007 - Immunization Recommendations and Requirements
Vaccination programs offer countries in the developing world the opportunity to fast-forward economic progress along with combating infectious disease, eradicating extreme poverty, reducing child mortality, and improving maternal health. The Twelfth Annual Colloquium gathered world experts in health policy and vaccine financing to address key factors impacting developing country immunization efforts. 
Leaders worldwide have embraced mass vaccinations campaigns to eradicate infectious diseases like smallpox, and now polio; yet no group has endeavored to prepare for influenza pandemic on a global scale. Alignment of national interests with global health policy poses challenges. Further, there is great disparity in policies for prevention and treatment of annual epidemic influenza, which typically results in significant morbidity and mortality.
At the Ninth Annual Colloquium, challenges to vaccine supply security were identified and four task forces were subsequently organized to pursue specific solutions in greater depth. The task forces considered four areas of concern:
Stockpiling, Financing, International Commission on Harmonization, and Advocacy. 
The availability of vaccines is a global imperative for public
health that is too important to be left to chance. The colloquium
addressed the fragility of national and global vaccine supplies,
with experts generating strategies to restore this vital resource
for public health. Key themes addressed pertained to return
on investment in the vaccine industry, the regulatory process,
vaccines as a national priority, and adequate vaccine capacity.
Two documents produced following the colloquium are available
here. A white paper analyzes the vaccine supply issue with a
list of pathways to vaccine shortage solutions. 
What benefits do the next generation of vaccines hold for the developed and developing countries of the world? The promise is great and turns upon highly specialized technologies and their attendant intellectual property considerations. The Eighth Annual Colloquium explores how researchers building vaccines for international public health initiatives can benefit from the great vaccine development resources available in the private sector. 
Neglected vaccines mean neglected children. Throughout the developing world, thousands of children suffer and die from malaria, TB, and HIV/AIDS each year. These diseases destroy untold potential and countless years of productive life. They prevent economic development and leave large sections of the world impoverished. Although vaccines would save them, the value of the market in the developing world is so limited that companies that need to make a profit in order to exist invest their efforts and resources elsewhere. If the market is left to its own workings, these vaccines—and children in the poorest countries - will remain neglected. 
The Sabin Vaccine Institute convened leaders of the
international public health community, biomedical scientists,
government officials, economists, and representatives from foundations,
the vaccine industry and international financial agencies to discuss
global immunization and propose solutions to the challenge of
financing vaccine development and implementing immunization programs
in the developing world. The participants agreed that the expanded
use of vaccines by developing countries, as well as increased
efforts to develop vaccines for deadly diseases that exert high
social burden, must be accorded a central role in international
strategies for improved public health, poverty reduction, and
economic development in the poorest countries. 
A report of key findings and implications of a survey of self-funded employers. In order to obtain a qualitative understanding of immunization coverage offered by self-funded employers in their health benefit plans, the Sabin Institute sponsored a survey in three states (Connecticut, Pennsylvania, Texas). This survey was conducted to collect information that would enable the Sabin Institute, the Aetna Foundation, child health advocates and policy makers to formulate specific strategies more effectively and thus achieve greater levels of immunization against preventable diseases. 
